These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2322293)

  • 1. Relationship between reductive drug metabolism in tumour tissue of anthracyclines in microspherical form and anti-tumour activity.
    Willmott N; Cummings J; Marley E; Smyth JF
    Biochem Pharmacol; 1990 Mar; 39(6):1055-62. PubMed ID: 2322293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The consequences of doxorubicin quinone reduction in vivo in tumour tissue.
    Cummings J; Willmott N; Hoey BM; Marley ES; Smyth JF
    Biochem Pharmacol; 1992 Dec; 44(11):2165-74. PubMed ID: 1472081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased anti-tumor effect of adriamycin-loaded albumin microspheres is associated with anaerobic bioreduction of drug in tumor tissue.
    Willmott N; Cummings J
    Biochem Pharmacol; 1987 Feb; 36(4):521-6. PubMed ID: 3827939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative cardiotoxicity and antitumour activity of doxorubicin (adriamycin) and 4'-deoxydoxorubicin and the relationship to in vivo disposition and metabolism in the target tissues.
    Cummings J; Willmott N; More I; Kerr DJ; Morrison JG; Kaye SB
    Biochem Pharmacol; 1987 May; 36(9):1521-6. PubMed ID: 3579988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covalent coupling of doxorubicin in protein microspheres is a major determinant of tumour drug disposition.
    Cummings J; Willmott N; Marley E; Smyth J
    Biochem Pharmacol; 1991 Jun; 41(12):1849-54. PubMed ID: 2039540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin-loaded casein microspheres: protein nature of drug incorporation.
    Willmott N; Magee GA; Cummings J; Halbert GW; Smyth JF
    J Pharm Pharmacol; 1992 Jun; 44(6):472-5. PubMed ID: 1359070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between tumour drug disposition and the antitumour activity of doxorubicin-loaded microspheres: implications for the drugs' in vivo mechanism of action.
    Cummings J; Willmott N; Marley EC; Smyth JF
    Biochem Pharmacol; 1993 Jun; 45(12):2550-3. PubMed ID: 8328991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of albumin and casein microspheres as a carrier for doxorubicin.
    Chen Y; Willmott N; Anderson J; Florence AT
    J Pharm Pharmacol; 1987 Dec; 39(12):978-85. PubMed ID: 2894445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The enzymology of doxorubicin quinone reduction in tumour tissue.
    Cummings J; Allan L; Willmott N; Riley R; Workman P; Smyth JF
    Biochem Pharmacol; 1992 Dec; 44(11):2175-83. PubMed ID: 1472082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity in mice of 4'-deoxydoxorubicin in comparison with doxorubicin.
    Casazza AM; Savi G; Pratesi G; Di Marco A
    Eur J Cancer Clin Oncol; 1983 Mar; 19(3):411-8. PubMed ID: 6683178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target organ disposition and plasma pharmacokinetics of doxorubicin incorporated into albumin microspheres after intrarenal arterial administration.
    Kerr DJ; Willmott N; McKillop JH; Cummings J; Lewi HJ; McArdle CS
    Cancer; 1988 Sep; 62(5):878-83. PubMed ID: 3409170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between cyclophosphamide and doxorubicin metabolism in rats. II. Effect of cyclophosphamide on the aldoketoreductase system.
    Dodion P; Akman SR; Tamburini JM; Riggs CE; Colvin OM; Bachur NR
    J Pharmacol Exp Ther; 1986 Apr; 237(1):271-4. PubMed ID: 3514847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encapsulation of mitomycin C in albumin microspheres markedly alters pharmacokinetics, drug quinone reduction in tumour tissue and antitumour activity. Implications for the drugs' in vivo mechanism of action.
    Cummings J; Allan L; Smyth JF
    Biochem Pharmacol; 1994 Apr; 47(8):1345-56. PubMed ID: 8185643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical and biological characterization of 4'-iodo-4'-deoxydoxorubicin.
    Barbieri B; Giuliani FC; Bordoni T; Casazza AM; Geroni C; Bellini O; Suarato A; Gioia B; Penco S; Arcamone F
    Cancer Res; 1987 Aug; 47(15):4001-6. PubMed ID: 3607745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic metabolism of doxorubicin in mice and rats.
    Vrignaud P; Londos-Gagliardi D; Robert J
    Eur J Drug Metab Pharmacokinet; 1986; 11(2):101-5. PubMed ID: 3770010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy.
    Kaminskas LM; McLeod VM; Ryan GM; Kelly BD; Haynes JM; Williamson M; Thienthong N; Owen DJ; Porter CJ
    J Control Release; 2014 Jun; 183():18-26. PubMed ID: 24637466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of DNA breakage in cytotoxicity of doxorubicin, 9-deoxydoxorubicin, and 4-demethyl-6-deoxydoxorubicin in murine leukemia P388 cells.
    Capranico G; De Isabella P; Penco S; Tinelli S; Zunino F
    Cancer Res; 1989 Apr; 49(8):2022-7. PubMed ID: 2702645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of an anticancer drug and a chemosensitizer to murine breast sarcoma by intratumoral injection of sulfopropyl dextran microspheres.
    Liu Z; Ballinger JR; Rauth AM; Bendayan R; Wu XY
    J Pharm Pharmacol; 2003 Aug; 55(8):1063-73. PubMed ID: 12956895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence assays and pharmacokinetic studies of 4'-deoxydoxorubicin and doxorubicin in organs of mice bearing solid tumors.
    Formelli F; Pollini C; Casazza AM; di Marco A; Mariani A
    Cancer Chemother Pharmacol; 1981; 5(3):139-44. PubMed ID: 7296751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of adriamycin and 4'-deoxydoxorubicin on cell survival of human lung tumour cells grown in monolayer and as spheroids.
    Kerr DJ; Wheldon TE; Kerr AM; Freshney RI; Kaye SB
    Br J Cancer; 1986 Sep; 54(3):423-9. PubMed ID: 3756078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.